CMS Suspends Prior Authorization for Osteogenesis Stimulators

Effective August 28, 2024, CMS is suspending prior authorization requirements for HCPCS codes E0747, E0748, and E0760 due to continued confusion over some noninvasive osteogenesis stimulators and whether they comply with the DME three-year expected life requirement at 42 CFR 414.202. CMS plans to provide additional direction regarding the three-year expected life requirement at 42 CFR 414.202 in future notice and comment rulemaking.

Last Updated Sep 26 , 2024